Abstract
Intestinal T-cell lymphoma is a rare hematological malignancy that can present as primary intestinal lymphoma or as a manifestation of systemic disease. Primary involvement accounts for approximately 0.1% to 0.5% of all colorectal neoplasms. It is an aggressive disease with a poor prognosis and low survival rate. Inflammatory bowel disease, celiac disease, immunosuppression, and infectious etiologies, such as Epstein-Barr and human T-lymphotropic viruses, have been reported as risk factors, but no direct causal link has been established. Herein, we examine the case of a Hispanic man 69 years of age diagnosed with positive CD3, CD7, CD8, CD43, and Bcl-2 diffuse primary colorectal T-cell lymphoma. The patient did not exhibit a concomitant autoimmune or genetic disease. Because of the patient's history of polyps, surveillance colonoscopy was performed and the diagnosis was confirmed.
Cite
CITATION STYLE
Grigg-Gutierrez, N. M., Estremera-Marcial, R., Cáceres, W. W., & Toro, D. H. (2015). Primary enteropathy-associated T-cell lymphoma type 2: An emerging entity? Cancer Control, 22(2), 242–247. https://doi.org/10.1177/107327481502200218
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.